CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-02 | Roberts M Scot Chief Scientific Officer | Grant or award · Restricted Stock Units | +31,100 | 31,100 | ||
| 2022-02-01 | Harris Matthew Scott Chief Medical Officer | Option exercise | +6,166 | 13,728 | ||
| 2022-02-01 | Harris Matthew Scott Chief Medical Officer | Shares withheld for taxes | −2,183 | $7.98 | $17K | 11,545 |
| 2022-02-01 | Harris Matthew Scott Chief Medical Officer | Option exercise · Restricted Stock Units | −6,166 | 18,498 | ||
| 2022-02-01 | Garg Vipin K President and CEO | Option exercise | +16,545 | 300,503 | ||
| 2022-02-01 | Garg Vipin K President and CEO | Shares withheld for taxes | −7,655 | $7.98 | $61K | 292,848 |
| 2022-02-01 | Garg Vipin K President and CEO | Option exercise · Restricted Stock Units | −16,545 | 49,636 | ||
| 2022-02-01 | Roberts M Scot Chief Scientific Officer | Option exercise | +6,166 | 19,883 | ||
| 2022-02-01 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −2,183 | $7.98 | $17K | 17,700 |
| 2022-02-01 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −6,166 | 18,498 | ||
| 2022-01-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +1,800 | $6.86 | $12K | 7,562 |
| 2022-01-31 | Garg Vipin K President and CEO | Grant or award | +2,757 | $6.86 | $19K | 283,958 |
| 2022-01-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +2,106 | $6.86 | $14K | 13,717 |
| 2022-01-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −2,355 | $7.20 | $17K | 281,201 |
| 2022-01-25 | Drutz David Director | Option exercise | +70 | $2.40 | $168 | 17,882 |
| 2022-01-25 | Drutz David Director | Option exercise · Stock Options (option to buy) | −70 | 69 | ||
| 2022-01-06 | GILL JOHN Director | Gift | −2,714 | 0 | ||
| 2021-12-31 | Eisenstadt Richard I Chief Financial Officer | Grant or award · Stock Options (option to buy) | +150,000 | 150,000 | ||
| 2021-12-31 | Eisenstadt Richard I Chief Financial Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2021-12-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −3,007 | $8.93 | $27K | 283,556 |
Page 18 of 29 · 568 trades